Upregulated m6A modification contributes to tumor progression by maintaining SOX2 expression in CRC cells through IGF2 mRNA binding proteins 2 (IGF2BP2)-dependent mechanisms (14, 15). The gene discussed is IGF2BP2; the disease is colorectal carcinoma.